Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer BREAST CANCER RESEARCH Krop, I. E., Modi, S., LoRusso, P. M., Pegram, M., Guardino, E., Althaus, B., Lu, D., Strasak, A., Elias, A. 2016; 18

View details for DOI 10.1186/s13058-016-0691-7

View details for Web of Science ID 000372492000002